COO
NasdaqCOOPER COMPANIES, INC.
Health Care, Health Care Supplies
$74.23
close 7 Aug 2026
+4.73%
52-week change
$14.47B
market cap
$58.89
$89.83
52-week range
Expected price
Expected price
$45.83 – $56.01
Current price
$74.23
Signal
Could be overvalued
A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.
Current multiples
P/E (TTM)63.44x
P/S (TTM)3.42x
P/B1.76x
EV/EBITDA (TTM)18.98x
FCF yield (TTM)3.94%
PEG (TTM, GAAP)—
Context
P/E, own 5-year average41.79x
P/E, sector median29.65x*
Price at 5-year median P/E$50.63*
Forward — analyst consensus
Forward P/E (FY2026)16.04x*
Forward P/E (FY2027)14.86x
Forward PEG2.01*
Consensus EPS FY2026 (16 analysts)$4.63
EPS growth (FY2026→FY2027)7.97%
Revenue growth (FY2026)5.24%
Street view
Price target (mean)$81.21*
Target upside9.41%
Ratings (buy / hold / sell)10 / 6 / 0
FY2026 EPS revisions, 30d (up / down)0 / 2
5-year history
Dashed line: average of month-end values
P/E (TTM)
P/S (TTM)
P/B
FCF yield (TTM)
Dividend yield
period to 30 Apr 2026, filed 5 Jun 2026, close 7 Aug 2026
Discounted cash flow
Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.
Free cash flow, last ten years and TTM
5Y CAGR +19.74%10Y CAGR +11.36%
Assumptions
As filed — not assumptions
Current price$74.23
Cash & equivalents$138.80M
Total debt$2.46B
Shares outstanding194.90M
Result
DCF price per share$194.76
Current price$74.23
Margin of safety+162.38%
PV of years 1–10$10.49B
PV of terminal value$29.79B
Equity value$37.96B
Market-implied growth+8.37%
Projected FCF, years 1–10
Hover for PV and growth
Projection detail
Override growth for any year; blank years use the uniform rate
| Year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | Terminal |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth, % | 2.5 | ||||||||||
| FCF | $681.92M | $816.53M | $977.71M | $1.17B | $1.40B | $1.68B | $2.01B | $2.41B | $2.88B | $3.45B | $64.31B |
| PV | $631.41M | $700.04M | $776.14M | $860.51M | $954.05M | $1.06B | $1.17B | $1.30B | $1.44B | $1.60B | $29.79B |
period to 30 Apr 2026, filed 5 Jun 2026, close 7 Aug 2026